NCT02093663 2021-06-09
PACE
Takeda
Phase 3 Completed
Clinical Trials
4 trialsNCT02077777 2016-12-02
Chemopreventive Action of Mesalazine on Colorectal Cancer: a Pilot Study for an "in Vivo" Evaluation of the Molecular Effects on β-catenin Signaling Pathway.
SOFAR S.p.A.
Phase 2 Completed
NCT01894685 2015-12-08
Mesalazine Effects in Sporadic Colorectal Adenoma Patients
UMC Utrecht
Phase 2 Completed
NCT02376478 2015-03-03
On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection
Medical University of Vienna
Completed